CureVac downgraded by B of A Securities with a new price target

1/21/22 7:00:47 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

B of A Securities downgraded CureVac from Neutral to Underperform and set a new price target of $20.00 from $55.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CVAC

Date	Price Target	Rating	Analyst
6/13/2025	$5.00	Buy → Hold	Jefferies
4/25/2024	$12.00 → $4.00	Outperform → Market Perform	Leerink Partners
6/8/2023	$13.00	Outperform	SVB Securities
1/19/2023	$8.00 → $18.00	Neutral → Buy	UBS
1/9/2023	$9.00 → $21.00	Hold → Buy	Jefferies
1/21/2022	$55.00 → $20.00	Neutral → Underperform	B of A Securities
1/18/2022	$52.00	Market Outperform	JMP Securities
10/22/2021	$35.00	Hold	Deutsche Bank